Novel transcript, antisense to Smoothelin

This entry represents a natural antisense transcript (NAT) with sequence overlap to the SMTN (Smoothelin) gene. Natural antisense transcripts are non-coding RNAs transcribed from the opposite DNA strand relative to a sense gene, often overlapping with part of the sense gene[2]. Many NATs regulate gene expression at the transcriptional or post-transcriptional level, for example modifying chromatin state, interfering with splicing, blocking translation, or masking small RNA binding sites[1][2]. The biological and clinical relevance of most NATs is not yet fully established. For ENSG00000273387, there is currently no evidence of it acting as a conventional drug, receptor, or protein target, nor is there published information about its functional impact on smoothelin or disease processes. The "novel transcript, antisense to SMTN" remains functionally uncharacterized in the biomedical literature and is primarily annotated in genome projects as a locus for further study. In summary: ENSG00000273387 ("novel transcript, antisense to SMTN") is a non-coding natural antisense RNA with unknown biological or therapeutic significance and should not be considered a therapeutic target with current scientific evidence.

Other names

ENSG00000273387antisense to SMTN